The Department of Health and Human Services asked the Department of Justice to investigate the company for potential violations of the Food, Drug, and Cosmetic Act (FDCA)
Broadly, they fall into three categories: GLP-1-focused startups like Found and SkinnyRx that exist solely to prescribe weight loss medication
Hair, skin, energy, body composition, and recovery are all interconnected
Your GI tract is a robust and intricate system with its own internal biome
At Ivm, were committed to offering treatments that deliver measurable results, even when that means saying no to products that sound appealing but lack scientific support
Eli Lilly is also developing a drug called retatrutide, that targets three receptors (glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors)